

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.63272803 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63272803 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.28818277 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28818277 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.84300313 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.38306561 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.20614562 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.20614562 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.20614562 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.08020850 |
| 11 | epoxygenase P450 pathway (GO:0019373) | 6.07597706 |
| 12 | regulation of plasminogen activation (GO:0010755) | 5.97971897 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.95747743 |
| 14 | exogenous drug catabolic process (GO:0042738) | 5.95543754 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.83780241 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.81404093 |
| 17 | urea metabolic process (GO:0019627) | 5.74024443 |
| 18 | urea cycle (GO:0000050) | 5.74024443 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.71278341 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.62482004 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58922587 |
| 22 | intestinal cholesterol absorption (GO:0030299) | 5.58194018 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.53218114 |
| 24 | omega-hydroxylase P450 pathway (GO:0097267) | 5.52004270 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.46055757 |
| 26 | protein carboxylation (GO:0018214) | 5.45403286 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45403286 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.40636525 |
| 29 | cysteine metabolic process (GO:0006534) | 5.36135002 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.33731813 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.27147467 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.13215740 |
| 33 | bile acid metabolic process (GO:0008206) | 5.09407052 |
| 34 | regulation of complement activation (GO:0030449) | 5.07757402 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.96514600 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.93511941 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.88776533 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86860221 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.84922981 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.82624782 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.82624782 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.82624782 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.82512216 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.76695115 |
| 45 | acute-phase response (GO:0006953) | 4.73599771 |
| 46 | protein-lipid complex subunit organization (GO:0071825) | 4.71833826 |
| 47 | regulation of apoptotic cell clearance (GO:2000425) | 4.70374086 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.67505449 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.67505449 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.65317546 |
| 51 | phospholipid efflux (GO:0033700) | 4.62885664 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.58667156 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.58667156 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.55639481 |
| 55 | lysine metabolic process (GO:0006553) | 4.53557479 |
| 56 | lysine catabolic process (GO:0006554) | 4.53557479 |
| 57 | negative regulation of blood coagulation (GO:0030195) | 4.50752480 |
| 58 | negative regulation of hemostasis (GO:1900047) | 4.50752480 |
| 59 | imidazole-containing compound metabolic process (GO:0052803) | 4.47999285 |
| 60 | glycine metabolic process (GO:0006544) | 4.45933516 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.43765563 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.42498708 |
| 63 | amine catabolic process (GO:0009310) | 4.42145669 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.42145669 |
| 65 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.40549593 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.39762595 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.38855771 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.37837425 |
| 69 | regulation of humoral immune response (GO:0002920) | 4.36284784 |
| 70 | glutamate metabolic process (GO:0006536) | 4.31763512 |
| 71 | negative regulation of protein activation cascade (GO:2000258) | 4.28727664 |
| 72 | cholesterol efflux (GO:0033344) | 4.28304185 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.26635920 |
| 74 | drug metabolic process (GO:0017144) | 4.23526579 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 4.19338869 |
| 76 | cellular glucuronidation (GO:0052695) | 4.17199203 |
| 77 | proline metabolic process (GO:0006560) | 4.15282289 |
| 78 | ethanol oxidation (GO:0006069) | 4.12196176 |
| 79 | positive regulation of hemostasis (GO:1900048) | 4.11287001 |
| 80 | positive regulation of blood coagulation (GO:0030194) | 4.11287001 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 4.11166872 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.10879652 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 4.09158435 |
| 84 | fibrinolysis (GO:0042730) | 4.08923601 |
| 85 | negative regulation of coagulation (GO:0050819) | 4.07778844 |
| 86 | serine family amino acid biosynthetic process (GO:0009070) | 4.05349603 |
| 87 | arginine metabolic process (GO:0006525) | 4.04878567 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04001234 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 4.02627974 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.99943040 |
| 91 | negative regulation of wound healing (GO:0061045) | 3.97188140 |
| 92 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.95944825 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.93461759 |
| 94 | ethanol metabolic process (GO:0006067) | 3.90859275 |
| 95 | lipoprotein metabolic process (GO:0042157) | 3.87910213 |
| 96 | cofactor catabolic process (GO:0051187) | 3.83453216 |
| 97 | drug catabolic process (GO:0042737) | 3.83320135 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.83295560 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.83295560 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.83133578 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.80039382 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79805997 |
| 103 | protein activation cascade (GO:0072376) | 3.79151766 |
| 104 | ketone body metabolic process (GO:1902224) | 3.79072684 |
| 105 | complement activation (GO:0006956) | 3.78163466 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77421980 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.77164270 |
| 108 | positive regulation of coagulation (GO:0050820) | 3.74965954 |
| 109 | regulation of cholesterol homeostasis (GO:2000188) | 3.74917570 |
| 110 | negative regulation of lipase activity (GO:0060192) | 3.72957164 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.72419669 |
| 112 | oxidative demethylation (GO:0070989) | 3.71395659 |
| 113 | organic acid catabolic process (GO:0016054) | 3.70979843 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.70979843 |
| 115 | sterol homeostasis (GO:0055092) | 3.70753025 |
| 116 | plasma lipoprotein particle organization (GO:0071827) | 3.70669554 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.68776013 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.68776013 |
| 119 | cytolysis (GO:0019835) | 3.68430259 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.68240626 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 3.65653807 |
| 122 | sterol transport (GO:0015918) | 3.63042561 |
| 123 | cholesterol transport (GO:0030301) | 3.63042561 |
| 124 | opsonization (GO:0008228) | 3.58638564 |
| 125 | NAD biosynthetic process (GO:0009435) | 3.58298085 |
| 126 | short-chain fatty acid metabolic process (GO:0046459) | 3.57723980 |
| 127 | intestinal absorption (GO:0050892) | 3.57195642 |
| 128 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.51489658 |
| 129 | acute inflammatory response (GO:0002526) | 3.50582323 |
| 130 | phenylpropanoid metabolic process (GO:0009698) | 3.46190596 |
| 131 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.43306016 |
| 132 | regulation of lipoprotein particle clearance (GO:0010984) | 3.41994787 |
| 133 | negative regulation of lipid transport (GO:0032369) | 3.37673509 |
| 134 | negative regulation of complement activation (GO:0045916) | 3.37029581 |
| 135 | peptidyl-glutamic acid modification (GO:0018200) | 3.35103323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42483928 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.25857666 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.05187602 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53579862 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.34036245 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.10395292 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80466274 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.07845033 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96446414 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05149796 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0738161 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98574466 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94637388 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67180864 |
| 15 | P68_20966046_ChIP-Seq_HELA_Human | 1.67091792 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60495140 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54444319 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54440535 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51275048 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49376021 |
| 21 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.47959346 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47867168 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47707812 |
| 24 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46906811 |
| 25 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.42502288 |
| 26 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41536486 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39975181 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37479537 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31798532 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31783215 |
| 31 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.30975570 |
| 32 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30009675 |
| 33 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27593908 |
| 34 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22244591 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22156609 |
| 36 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21281645 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21087285 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19778396 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18112452 |
| 40 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16592593 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12195686 |
| 42 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10704905 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06837817 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06145298 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05746557 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04890391 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04692968 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01337112 |
| 49 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98674066 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98275226 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98031215 |
| 52 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97562747 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96578904 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96416755 |
| 55 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95790675 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93843096 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93777638 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92949256 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92131254 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90713337 |
| 61 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90075823 |
| 62 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.89826482 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89117314 |
| 64 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.88301976 |
| 65 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.87031136 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86317621 |
| 67 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86239891 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85991945 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85445640 |
| 70 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83386366 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83325357 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82569572 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.81405299 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80421066 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80306180 |
| 76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79695269 |
| 77 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79407277 |
| 78 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.78859388 |
| 79 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.78439522 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78408521 |
| 81 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.78306961 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78301240 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77504344 |
| 84 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76966593 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76399513 |
| 86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.76107403 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75770245 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75460197 |
| 89 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.75425989 |
| 90 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73561441 |
| 91 | ERA_21632823_ChIP-Seq_H3396_Human | 0.73262414 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72696314 |
| 93 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.72174475 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72070679 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70611954 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67632846 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66336749 |
| 98 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65229363 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65000285 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64952848 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64425134 |
| 102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62159252 |
| 103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61326076 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60214918 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59871753 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58084943 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58084943 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57837567 |
| 109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57271784 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53537680 |
| 111 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52012015 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52010154 |
| 113 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51475666 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50961634 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50622060 |
| 116 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50160357 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50126919 |
| 118 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49304886 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.49172415 |
| 120 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.47090539 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46847906 |
| 122 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45767227 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.45386140 |
| 124 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44434005 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44323715 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44202296 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44199049 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43877469 |
| 129 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43607699 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43170374 |
| 131 | CBP_21632823_ChIP-Seq_H3396_Human | 0.43099591 |
| 132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42192555 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41800178 |
| 134 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41610108 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.40953728 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40883800 |
| 137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39985342 |
| 138 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38335807 |
| 139 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37718633 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37325516 |
| 141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36060995 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.34963046 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.33997784 |
| 144 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33424862 |
| 145 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33058208 |
| 146 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.33031050 |
| 147 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.32991938 |
| 148 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.32925826 |
| 149 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.32700608 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.32387961 |
| 151 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.32247463 |
| 152 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.31953696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.26355762 |
| 2 | MP0005360_urolithiasis | 7.49312777 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45119113 |
| 4 | MP0005365_abnormal_bile_salt | 6.13659403 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.07266243 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.28627948 |
| 7 | MP0003252_abnormal_bile_duct | 3.92336168 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.62263168 |
| 9 | MP0009840_abnormal_foam_cell | 3.32624548 |
| 10 | MP0005083_abnormal_biliary_tract | 3.18772411 |
| 11 | MP0003195_calcinosis | 2.85930893 |
| 12 | MP0005332_abnormal_amino_acid | 2.74414942 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60754969 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.41082130 |
| 15 | MP0000609_abnormal_liver_physiology | 2.20252052 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.10914320 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10569390 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.95708277 |
| 19 | MP0003868_abnormal_feces_composition | 1.89057465 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82954520 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.68107049 |
| 22 | MP0000566_synostosis | 1.67486473 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.65678887 |
| 24 | MP0001764_abnormal_homeostasis | 1.64441644 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55637062 |
| 26 | MP0009697_abnormal_copulation | 1.55466659 |
| 27 | MP0003011_delayed_dark_adaptation | 1.43235646 |
| 28 | MP0005451_abnormal_body_composition | 1.42609835 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.38578438 |
| 30 | MP0005409_darkened_coat_color | 1.37933083 |
| 31 | MP0003122_maternal_imprinting | 1.33826874 |
| 32 | MP0003186_abnormal_redox_activity | 1.24752640 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.23606102 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.21109903 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.21090387 |
| 36 | * MP0000598_abnormal_liver_morphology | 1.18755038 |
| 37 | MP0005647_abnormal_sex_gland | 1.14657783 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.12913331 |
| 39 | MP0002254_reproductive_system_inflammat | 1.09977084 |
| 40 | MP0000604_amyloidosis | 1.09663317 |
| 41 | MP0009764_decreased_sensitivity_to | 1.07318717 |
| 42 | MP0003879_abnormal_hair_cell | 1.06466858 |
| 43 | MP0009763_increased_sensitivity_to | 1.05122725 |
| 44 | MP0001915_intracranial_hemorrhage | 1.02479693 |
| 45 | MP0010368_abnormal_lymphatic_system | 0.99125404 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.92127589 |
| 47 | MP0008469_abnormal_protein_level | 0.91370041 |
| 48 | MP0009642_abnormal_blood_homeostasis | 0.87579333 |
| 49 | MP0002249_abnormal_larynx_morphology | 0.87577807 |
| 50 | MP0005408_hypopigmentation | 0.81537748 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 0.79822164 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.79191763 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.79186783 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.77097529 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 0.74680196 |
| 56 | MP0005670_abnormal_white_adipose | 0.74645407 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 0.74330036 |
| 58 | MP0002971_abnormal_brown_adipose | 0.73351290 |
| 59 | MP0002876_abnormal_thyroid_physiology | 0.72304035 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 0.70942082 |
| 61 | MP0003878_abnormal_ear_physiology | 0.70942082 |
| 62 | MP0005334_abnormal_fat_pad | 0.69365605 |
| 63 | MP0001661_extended_life_span | 0.66751829 |
| 64 | MP0003690_abnormal_glial_cell | 0.65088364 |
| 65 | MP0004130_abnormal_muscle_cell | 0.64971705 |
| 66 | MP0009053_abnormal_anal_canal | 0.64574452 |
| 67 | MP0005535_abnormal_body_temperature | 0.64500248 |
| 68 | MP0005266_abnormal_metabolism | 0.64151782 |
| 69 | MP0000003_abnormal_adipose_tissue | 0.63989119 |
| 70 | MP0003329_amyloid_beta_deposits | 0.60627792 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.60544492 |
| 72 | MP0000639_abnormal_adrenal_gland | 0.59942209 |
| 73 | MP0003136_yellow_coat_color | 0.57898315 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 0.56961923 |
| 75 | MP0001756_abnormal_urination | 0.56546757 |
| 76 | MP0002282_abnormal_trachea_morphology | 0.56060774 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.55812965 |
| 78 | MP0000678_abnormal_parathyroid_gland | 0.55615325 |
| 79 | MP0005448_abnormal_energy_balance | 0.54955933 |
| 80 | MP0005023_abnormal_wound_healing | 0.53859529 |
| 81 | MP0005257_abnormal_intraocular_pressure | 0.52333446 |
| 82 | MP0003436_decreased_susceptibility_to | 0.51129215 |
| 83 | MP0005395_other_phenotype | 0.50318956 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.50293056 |
| 85 | MP0003718_maternal_effect | 0.49772435 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.49102585 |
| 87 | MP0002928_abnormal_bile_duct | 0.47100357 |
| 88 | MP0003724_increased_susceptibility_to | 0.46514648 |
| 89 | MP0008873_increased_physiological_sensi | 0.46148197 |
| 90 | MP0004272_abnormal_basement_membrane | 0.45319227 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.45188322 |
| 92 | MP0008874_decreased_physiological_sensi | 0.45014879 |
| 93 | MP0003123_paternal_imprinting | 0.44966838 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.44848574 |
| 95 | MP0002822_catalepsy | 0.44506505 |
| 96 | MP0004381_abnormal_hair_follicle | 0.43376221 |
| 97 | MP0003075_altered_response_to | 0.40624489 |
| 98 | MP0003632_abnormal_nervous_system | 0.40330708 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.40217072 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.40129649 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.40048164 |
| 102 | MP0000579_abnormal_nail_morphology | 0.39840497 |
| 103 | MP0002933_joint_inflammation | 0.39807830 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.39695154 |
| 105 | MP0005166_decreased_susceptibility_to | 0.39654529 |
| 106 | MP0003953_abnormal_hormone_level | 0.39592961 |
| 107 | MP0005248_abnormal_Harderian_gland | 0.38186809 |
| 108 | MP0009672_abnormal_birth_weight | 0.37259198 |
| 109 | MP0004043_abnormal_pH_regulation | 0.37223538 |
| 110 | MP0005330_cardiomyopathy | 0.36797628 |
| 111 | MP0008872_abnormal_physiological_respon | 0.36361607 |
| 112 | MP0006082_CNS_inflammation | 0.36104585 |
| 113 | MP0002837_dystrophic_cardiac_calcinosis | 0.35407152 |
| 114 | MP0002796_impaired_skin_barrier | 0.35249176 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.35132354 |
| 116 | MP0001243_abnormal_dermal_layer | 0.35013929 |
| 117 | MP0003115_abnormal_respiratory_system | 0.34813602 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.33537541 |
| 119 | MP0009384_cardiac_valve_regurgitation | 0.32699876 |
| 120 | MP0002970_abnormal_white_adipose | 0.32586071 |
| 121 | MP0000249_abnormal_blood_vessel | 0.32535176 |
| 122 | MP0009115_abnormal_fat_cell | 0.32072902 |
| 123 | MP0000858_altered_metastatic_potential | 0.31946339 |
| 124 | MP0001853_heart_inflammation | 0.31325872 |
| 125 | MP0004883_abnormal_blood_vessel | 0.31202417 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.31104330 |
| 127 | MP0002168_other_aberrant_phenotype | 0.30177779 |
| 128 | MP0002132_abnormal_respiratory_system | 0.30087856 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.29839973 |
| 130 | MP0001881_abnormal_mammary_gland | 0.28972979 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.28846801 |
| 132 | MP0002060_abnormal_skin_morphology | 0.25726986 |
| 133 | MP0003453_abnormal_keratinocyte_physiol | 0.25144061 |
| 134 | MP0005164_abnormal_response_to | 0.25096316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.49283200 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42047976 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.30134345 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71965663 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.67592353 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.42205392 |
| 7 | Xanthomatosis (HP:0000991) | 6.32134059 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.58846041 |
| 9 | Complement deficiency (HP:0004431) | 5.44331853 |
| 10 | Joint hemorrhage (HP:0005261) | 4.92754328 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.82164325 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.60498572 |
| 13 | Epidermoid cyst (HP:0200040) | 4.56597008 |
| 14 | Hyperammonemia (HP:0001987) | 4.54868493 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40495215 |
| 16 | Hyperglycinemia (HP:0002154) | 4.36911135 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.27595880 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.24501526 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24151172 |
| 20 | Ketosis (HP:0001946) | 4.19462205 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.10256735 |
| 22 | Fat malabsorption (HP:0002630) | 4.09897828 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08515433 |
| 24 | Abnormality of complement system (HP:0005339) | 3.98958835 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.85183518 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85183518 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.85073561 |
| 28 | Hyperglycinuria (HP:0003108) | 3.83461110 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81711861 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.79663703 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70342302 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.64530911 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.37213270 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29987490 |
| 35 | Spontaneous abortion (HP:0005268) | 3.24207235 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24138030 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.14672666 |
| 38 | Myocardial infarction (HP:0001658) | 3.08269420 |
| 39 | Steatorrhea (HP:0002570) | 3.07069985 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03926548 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.03918742 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.02019801 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 3.01632481 |
| 44 | Ketoacidosis (HP:0001993) | 2.91529875 |
| 45 | Purpura (HP:0000979) | 2.85559371 |
| 46 | Skin nodule (HP:0200036) | 2.79411360 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.76983940 |
| 48 | Metabolic acidosis (HP:0001942) | 2.71302726 |
| 49 | Acanthocytosis (HP:0001927) | 2.69246633 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.63353041 |
| 51 | Vascular calcification (HP:0004934) | 2.60266280 |
| 52 | Abnormal gallbladder morphology (HP:0012437) | 2.53329748 |
| 53 | Lethargy (HP:0001254) | 2.52144951 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.49612654 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49612654 |
| 56 | Mitral stenosis (HP:0001718) | 2.49185322 |
| 57 | Glomerulonephritis (HP:0000099) | 2.49123183 |
| 58 | Vaginal fistula (HP:0004320) | 2.49121806 |
| 59 | Cholelithiasis (HP:0001081) | 2.48180563 |
| 60 | Spastic diplegia (HP:0001264) | 2.47040573 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.45479808 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43289039 |
| 63 | Gout (HP:0001997) | 2.42151201 |
| 64 | Amyloidosis (HP:0011034) | 2.40748446 |
| 65 | Cholecystitis (HP:0001082) | 2.39027374 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.39027374 |
| 67 | Gingival bleeding (HP:0000225) | 2.37498856 |
| 68 | Neonatal onset (HP:0003623) | 2.34258774 |
| 69 | Cerebral edema (HP:0002181) | 2.33496488 |
| 70 | Irritability (HP:0000737) | 2.32189777 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.30360398 |
| 72 | Malnutrition (HP:0004395) | 2.29278727 |
| 73 | Menorrhagia (HP:0000132) | 2.23653718 |
| 74 | Esophageal varix (HP:0002040) | 2.20945798 |
| 75 | Poikilocytosis (HP:0004447) | 2.19501740 |
| 76 | Thrombophlebitis (HP:0004418) | 2.18471215 |
| 77 | Osteomalacia (HP:0002749) | 2.12997786 |
| 78 | Brushfield spots (HP:0001088) | 2.11652381 |
| 79 | Pancreatitis (HP:0001733) | 2.11614375 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.11179443 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.10656775 |
| 82 | Enlarged kidneys (HP:0000105) | 2.10484780 |
| 83 | Late onset (HP:0003584) | 2.10374930 |
| 84 | Widely patent fontanelles and sutures (HP:0004492) | 2.05717934 |
| 85 | Opisthotonus (HP:0002179) | 2.04684753 |
| 86 | Abnormality of the gallbladder (HP:0005264) | 2.04239298 |
| 87 | Vomiting (HP:0002013) | 2.02621094 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 1.99548117 |
| 89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99269200 |
| 90 | Ulnar bowing (HP:0003031) | 1.95685056 |
| 91 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95052325 |
| 92 | Generalized aminoaciduria (HP:0002909) | 1.94104337 |
| 93 | Rickets (HP:0002748) | 1.93787192 |
| 94 | Mucopolysacchariduria (HP:0008155) | 1.92478288 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92478288 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 1.89362356 |
| 97 | Hypophosphatemic rickets (HP:0004912) | 1.87776891 |
| 98 | Abnormality of carpal bone ossification (HP:0006257) | 1.86337643 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.84722251 |
| 100 | Epistaxis (HP:0000421) | 1.84466853 |
| 101 | Renal cortical cysts (HP:0000803) | 1.81858001 |
| 102 | Reticulocytosis (HP:0001923) | 1.81677099 |
| 103 | Elevated alkaline phosphatase (HP:0003155) | 1.81593291 |
| 104 | Elevated hepatic transaminases (HP:0002910) | 1.81027478 |
| 105 | Hydroxyprolinuria (HP:0003080) | 1.80820655 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 1.80820655 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79473862 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79416632 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79416632 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79416632 |
| 111 | Status epilepticus (HP:0002133) | 1.78714867 |
| 112 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78443858 |
| 113 | Nephritis (HP:0000123) | 1.77390660 |
| 114 | Facial shape deformation (HP:0011334) | 1.76658270 |
| 115 | Potter facies (HP:0002009) | 1.76658270 |
| 116 | Alkalosis (HP:0001948) | 1.75348437 |
| 117 | Abnormal tarsal ossification (HP:0008369) | 1.74542301 |
| 118 | Thin bony cortex (HP:0002753) | 1.74441335 |
| 119 | Bifid scrotum (HP:0000048) | 1.73235219 |
| 120 | Pulmonary embolism (HP:0002204) | 1.71564498 |
| 121 | Arthropathy (HP:0003040) | 1.71216926 |
| 122 | Increased serum ferritin (HP:0003281) | 1.66579200 |
| 123 | Hypophosphatemia (HP:0002148) | 1.65899190 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.65563790 |
| 125 | Reduced antithrombin III activity (HP:0001976) | 1.65108987 |
| 126 | Abnormal delivery (HP:0001787) | 1.61137321 |
| 127 | Hypertriglyceridemia (HP:0002155) | 1.56750427 |
| 128 | Mesangial abnormality (HP:0001966) | 1.54218288 |
| 129 | Asymmetry of the thorax (HP:0001555) | 1.51469985 |
| 130 | Retinal atrophy (HP:0001105) | 1.48649762 |
| 131 | Joint swelling (HP:0001386) | 1.48209160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.88666752 |
| 2 | FGFR4 | 4.72576239 |
| 3 | ERN1 | 4.62718295 |
| 4 | SIK1 | 4.61803194 |
| 5 | WNK4 | 3.35038240 |
| 6 | TAOK3 | 3.28744922 |
| 7 | ERBB4 | 2.97836112 |
| 8 | INSRR | 2.85611415 |
| 9 | PKN2 | 2.34056367 |
| 10 | MAP2K4 | 2.30657138 |
| 11 | MST1R | 2.05106037 |
| 12 | CDK12 | 2.00109878 |
| 13 | MAPK11 | 1.96525368 |
| 14 | FLT3 | 1.93179940 |
| 15 | TRIB3 | 1.88317796 |
| 16 | TYK2 | 1.87100055 |
| 17 | PIK3CG | 1.77175782 |
| 18 | PDGFRA | 1.72291953 |
| 19 | SIK2 | 1.63814608 |
| 20 | TYRO3 | 1.62622559 |
| 21 | LATS1 | 1.61119659 |
| 22 | PTK6 | 1.54309164 |
| 23 | DAPK2 | 1.47785338 |
| 24 | ABL2 | 1.41658830 |
| 25 | WNK1 | 1.37874195 |
| 26 | NEK9 | 1.34225267 |
| 27 | EEF2K | 1.33700000 |
| 28 | KDR | 1.32196077 |
| 29 | JAK2 | 1.31778401 |
| 30 | FGFR2 | 1.28172044 |
| 31 | GRK6 | 1.24079589 |
| 32 | PINK1 | 1.22676762 |
| 33 | MAP3K7 | 1.22084360 |
| 34 | FRK | 1.21712828 |
| 35 | PIK3CA | 1.19475289 |
| 36 | EPHA2 | 1.16212048 |
| 37 | NTRK3 | 1.11630493 |
| 38 | MAP2K3 | 1.11485401 |
| 39 | TBK1 | 1.11164028 |
| 40 | JAK1 | 1.09995646 |
| 41 | MAP3K10 | 1.09795732 |
| 42 | PRKAA2 | 1.09542434 |
| 43 | SMG1 | 1.07794636 |
| 44 | ERBB2 | 1.07737590 |
| 45 | DDR2 | 1.06372148 |
| 46 | AKT3 | 1.03564046 |
| 47 | MUSK | 1.02144396 |
| 48 | MAP3K14 | 0.99727037 |
| 49 | FGFR1 | 0.98590566 |
| 50 | MAPK4 | 0.98261471 |
| 51 | EPHB1 | 0.90187721 |
| 52 | PDK2 | 0.89547833 |
| 53 | MAPK15 | 0.87301208 |
| 54 | PRKCZ | 0.87221473 |
| 55 | MAP3K11 | 0.87197067 |
| 56 | CDK6 | 0.83221650 |
| 57 | MAP3K3 | 0.83197676 |
| 58 | CDC42BPA | 0.81933180 |
| 59 | MET | 0.79938660 |
| 60 | MAPK12 | 0.79196317 |
| 61 | PRPF4B | 0.76996499 |
| 62 | DYRK1B | 0.76433500 |
| 63 | MARK2 | 0.75978803 |
| 64 | EPHA3 | 0.75970915 |
| 65 | CSK | 0.75839491 |
| 66 | PRKACG | 0.75105193 |
| 67 | MAP3K2 | 0.73299801 |
| 68 | ZAP70 | 0.73263151 |
| 69 | IRAK3 | 0.71425160 |
| 70 | STK38L | 0.69800360 |
| 71 | CAMK1D | 0.68640491 |
| 72 | BLK | 0.68267925 |
| 73 | MAP2K6 | 0.66556408 |
| 74 | GSK3A | 0.66168313 |
| 75 | SGK3 | 0.65295851 |
| 76 | TIE1 | 0.64693437 |
| 77 | FGFR3 | 0.63964046 |
| 78 | CAMK2G | 0.63819809 |
| 79 | PRKAA1 | 0.63710457 |
| 80 | TGFBR2 | 0.61926849 |
| 81 | CSF1R | 0.61607464 |
| 82 | IKBKE | 0.60759313 |
| 83 | RIPK1 | 0.57491160 |
| 84 | PTK2 | 0.56605826 |
| 85 | MAPK7 | 0.55500001 |
| 86 | SGK1 | 0.54700887 |
| 87 | PDPK1 | 0.52428484 |
| 88 | PRKCQ | 0.51300640 |
| 89 | GRK1 | 0.46950028 |
| 90 | PKN1 | 0.45612269 |
| 91 | SGK2 | 0.45538297 |
| 92 | CDK4 | 0.44642062 |
| 93 | PDGFRB | 0.44450046 |
| 94 | CSNK1G1 | 0.42536772 |
| 95 | RPS6KB1 | 0.42280062 |
| 96 | TAOK2 | 0.42171554 |
| 97 | RPS6KC1 | 0.42144270 |
| 98 | RPS6KL1 | 0.42144270 |
| 99 | MAP3K5 | 0.41973045 |
| 100 | MAPKAPK3 | 0.41555977 |
| 101 | RPS6KA2 | 0.41334540 |
| 102 | PRKD2 | 0.40982938 |
| 103 | MAP3K13 | 0.40802506 |
| 104 | RET | 0.40672401 |
| 105 | IGF1R | 0.40080706 |
| 106 | MTOR | 0.39741425 |
| 107 | CDK7 | 0.39735019 |
| 108 | KSR2 | 0.39521553 |
| 109 | NEK2 | 0.39158847 |
| 110 | CSNK1D | 0.39048751 |
| 111 | MAP2K1 | 0.39001340 |
| 112 | ICK | 0.35186391 |
| 113 | EGFR | 0.34524563 |
| 114 | SRC | 0.34476821 |
| 115 | PRKCG | 0.34377093 |
| 116 | TNK2 | 0.33761390 |
| 117 | RPS6KA6 | 0.32968275 |
| 118 | CAMK1G | 0.32930645 |
| 119 | PDK1 | 0.32030685 |
| 120 | MAP3K6 | 0.31823496 |
| 121 | CAMK4 | 0.31683653 |
| 122 | EPHA4 | 0.31028505 |
| 123 | MAPK8 | 0.30307539 |
| 124 | FGR | 0.29789605 |
| 125 | MAP4K1 | 0.29498126 |
| 126 | SGK494 | 0.28339802 |
| 127 | SGK223 | 0.28339802 |
| 128 | NTRK1 | 0.27911386 |
| 129 | RPS6KA3 | 0.27787227 |
| 130 | MELK | 0.27318187 |
| 131 | MAP3K1 | 0.27166816 |
| 132 | BMX | 0.26255642 |
| 133 | PBK | 0.25762668 |
| 134 | ABL1 | 0.22919031 |
| 135 | PRKCA | 0.22886828 |
| 136 | CSNK1G2 | 0.21790572 |
| 137 | CSNK1G3 | 0.20416509 |
| 138 | ITK | 0.20024867 |
| 139 | MAPK3 | 0.19169804 |
| 140 | IRAK1 | 0.18780302 |
| 141 | MAP2K2 | 0.18620211 |
| 142 | LATS2 | 0.17168577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55730455 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64130501 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40772460 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31492624 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11083586 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85911974 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69147703 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67801516 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62639631 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57132780 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46594188 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34104087 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22580024 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11738904 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11106632 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06291260 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93940891 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92955515 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90549592 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90037584 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87357180 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85805923 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83367905 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78089022 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76589792 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75443710 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69919066 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68598119 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68571209 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65832199 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62101199 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56262548 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54492938 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51110502 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49480037 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48993796 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45793156 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33218016 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33027713 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32711799 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30501220 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29706058 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26899539 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.23479339 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22460915 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21534300 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21019574 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16856845 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11407430 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03208934 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02529180 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01767838 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01144216 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00336284 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99631660 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95507836 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87661804 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84901915 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.83888697 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83222452 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82575854 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70233198 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66334352 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63474893 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57705068 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52521966 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.46103113 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45231286 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43860192 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41300310 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37714408 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.36857102 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.30955763 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27195213 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26433411 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.24491034 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23914719 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23028293 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20447810 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17175412 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16213331 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.15591599 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.14674952 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10201751 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02070009 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2401763 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2386141 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2361145 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2276628 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | -0.2133624 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2085396 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2018592 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1823297 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1756297 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1735303 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1509574 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1481448 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1451541 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1422793 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1415332 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0958621 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0911071 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0852892 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.0794551 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0752998 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0727067 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0690687 |
| 108 | Lysosome_Homo sapiens_hsa04142 | -0.0600959 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0585436 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0273933 |

